FDA Investigator Jason Kwong
Jason Kwong has inspections in 1 countries as of 15 Nov 2023. Jason Kwong has collaborated with a combinined 3384 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
285
Last Inspection Date:
15 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adriana N Jimenez Lopez,
Alice S Tsao,
Allen Lou,
Althea A Williams,
Amber D Brodas,
Amy Constantine,
Amy Kim,
Amy L Singer,
Amy M Cramer,
Andrew F Cohen,
Andrew J Garufi,
Andrew J Molesky,
Anna M Alexander,
Anthony M Criscuolo, Jr,
Anthony R Rauert,
April J Brucklier,
Arduino Frankovic,
Arthur S Williams, Jr,
Ashley Defilippis,
Ashley Polizzotto,
Ayorinde O Babalola,
Barbara J Maulfair,
Benjamin Bustamante,
Bernandica Tsculac Stern,
Bernardica T Sculac Stern,
Betty M Ng Lee,
Brian M Brodman,
Brittney Hu,
Carrie E Jolly,
Cary Greene,
Cassandra Gasby,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Cosmon L Barrett,
Daniel Green,
David A Trent Carlson,
David I Cho,
David J Leray,
David R Delucia,
Deep R Parikh,
Denise L Terzian,
Denise R Beuttenmuller,
Dhaval H Patel,
Diane B Radice,
Dipesh K Shah,
Domenico Carbone,
Donald J Ullstrom,
Doreen P Gubbay,
Douglas G Ng,
Dung N Tran,
Edwin A Evangelista,
Emest F Bizjak,
Emilio Z Azukwu,
Eric J Reisenauer,
Eric Rothschild,
Feryal Ahmad,
Frank A Boardwick,
Frank Verni,
Gabriel Feng,
Gayle J Gehrman,
Gianine E Delade,
Gianine E Tompkins,
Gray,
Herrmann,
Hitesh R Patel,
Huascar Batista,
Iram R Hassan, PhD,
Irina Gaberman,
Isaac N Baah,
Jana J Lau,
Jane Chen,
Jeffrey A Reed,
Jennifer L Custodio,
Jerri E Lothrop,
John A Hollings,
John E Aghadia,
Johnmartin Jackson,
Jose O Hernandez,
Jose V Obando,
Joseph Duca,
Joseph H Procopio,
Joseph Maselli,
Joseph Milcetic,
Joseph O Sullivan,
Joseph S Tomao,
Joy F Canlas,
Joy P Matthias,
Judy Keihl,
Juliana Falla,
Karen A Spencer,
Karen E D'orazio,
Karen F Tomaziefski,
Karla M Valles,
Katherine M Alejo,
Kerry A Kurdilla,
Kevin J Flessa,
Kimberley A Ricketts,
Kimberly A Coward,
Kimberly N Garner,
King,
Kristen C Jackson,
Kristy L Bonner,
Kwong P Lee,
Laishan L Lam,
Lawrence R Johnson,
Leticia S Jones,
Lisa Mathew,
Loretta J Miller,
Lorie S Hannappel,
Lourdes A Faria Feldman,
Marjorie D Schultz,
Mary M Finn,
Matthew A Spataro,
Maximillian Lucci,
Melissa B Libby,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael R Dominick,
Michele C Murray Schrade,
Milan S Kunajukr,
Milan S Mcgorty,
Morgan J Matthews,
Morjorie D Schultz,
Mouhamed H Halwani,
Myra L Reed,
Nawab A Siddiqui,
Nazmul Hassan,
Nicholas J Morici,
Nicole Vaught,
Omolola A Shola Philips,
Onieka T Carpenter,
Pasquale L Leone,
Patricia A Ellis,
Patrick A Bowen,
Paul L Bellamy,
Paul M Gelfand,
Pearl L Gonzalez,
Perez,
Peter M Trunk,
Peter R Caparelli,
Phillip O Mathis,
Rachel E Wapniak,
Randolph Campos Santiago,
Raymond L Cheung,
Raymond Liu,
Raymond M Lam,
Regina Moore,
Richard D Manney,
Rita F Monfort,
Robert C Howard,
Ronald Ifraimov,
Ryan J Aguillon,
Samantha N Mccormick,
Samina S Khan,
Samuel A Francis,
Sarah A Meehan,
Sarah Forney,
Sarah K Graham,
Seemay A Lee,
Shamel Jaime,
Shannon A Dinardo,
Shantel S Brown,
Shantel S Tobias,
Sharon Ferraro,
Sherri J Liu,
Shirley S Wen,
Shreya Shah,
Spiridoula Dimopoulos,
State Agency,
Stephanie T Durso,
Susan M Halsted,
Suwaskie S Smith,
Taina Pierre Pierre,
Tamara M Simpson,
Tanvir Kaium,
Tara K Carmody,
Tara K Normandin,
Thomas Cote,
Tracy M Portelli,
Tressa T Lewis,
Vaishali J Patel,
Valerie A Potopsingh,
Valerie C Reed,
Vanessa M Williams,
Vincent T Duncan,
Virginia A Chung,
Virginia M Neufville,
Wai H Lam,
Wayne J Meyer,
William V Thompson,
Willy A Orantes,
Winston A Oliver,
Yasodra Singh,
Yu X Chen,
Yuyan Liang
Jason Kwong's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2017 | FDA 483 | Ocean 88 Trading Corp - Form 483, 2017-12-11 |
| January, 2024 | FDA 483 | Handylee Enterprises (USA) Corp. - Form 483, 2024-01-11 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more